| Period End Date | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 2.55%49,526.00 | 48,296.00 | 43,253.00 | 45,890.00 | 50,534.00 |
| Cost Of Revenue | 0.16%42,148.00 | 42,216.00 | 35,311.00 | 51,622.00 | 43,411.00 |
14.72%3,079.00 | 2,684.00 | 2,807.00 | - | - | |
| Selling, General, and Administrative | 14.72%3,079.00 | 2,684.00 | 2,807.00 | - | - |
| Costs And Expenses | 0.87%48,072.00 | 47,658.00 | 40,924.00 | 57,447.00 | 48,976.00 |
| Provision For Loan, Lease, And Other Losses | 1.61%183.00 | 186.00 | 173.00 | 139.00 | 154.00 |
| Operating Income/Loss | 127.90%1,454.00 | 638.00 | 2,329.00 | -11,557.00 | 1,558.00 |
| Nonoperating Income/Loss | 105.35%922.00 | 449.00 | 773.00 | 113.00 | 560.00 |
| Income/Loss From Equity Method Investments | 105.61%155.00 | -2,763.00 | 160.00 | -3,018.00 | 21.00 |
| Income/Loss From Continuing Operations Before Tax | 205.56%2,146.00 | -2,033.00 | 2,912.00 | -14,810.00 | 1,818.00 |
| Income Tax Expense/Benefit, Deferred | 105.93%56.00 | -945.00 | 64.00 | -4,018.00 | -733.00 |
| Income Tax Expense/Benefit | 113.64%97.00 | -711.00 | 361.00 | -3,756.00 | -630.00 |
254.99%2,049.00 | -1,322.00 | 2,551.00 | -11,054.00 | 2,448.00 | |
| Available To Common Stockholders, Basic | 254.41%2,049.00 | -1,327.00 | 2,548.00 | -11,064.00 | 2,447.00 |
| Attributable To Noncontrolling Interest | 100.00%- | 5.00 | 3.00 | 10.00 | 1.00 |
| Basic Average Shares | 0.08%3,990.00 | 3,987.00 | 3,991.00 | 2.00 | 3,983.00 |
| Diluted Average Shares | 2.23%4,076.00 | 3,987.00 | 4,071.00 | -47.00 | 4,048.00 |
| Basic Earnings Per Share | 254.55%0.51 | -0.33 | 0.64 | -2.78 | 0.61 |
| Diluted Earnings Per Share | 251.52%0.50 | -0.33 | 0.63 | -2.78 | 0.60 |
| Common Stock Dividends | 0.15 | 0.15 | 0.15 | - | 0.15 |
